Our team includes members of the Board of Directors, Management and Advisors.
Board of Directors
Sundar Rajendran, MD
Dan Kopacz, MD
Steven Eror, MBA
Oliver Ding, MBA
Steven Eror, MBA, Chief Executive Officer
Stephen Spencer, CPA, Chief Financial Officer
Sundar Rajendran, MD, Co-Chief Medical Officer
Dan Kopacz, MD, Co-Chief Medical Officer
Oliver Ding MBA, Vice President Development
Vicki Kaiser, Vice President Operations
Albert Rego, Ph.D., MBA, VP Regulatory Affairs
Co-Chief Medical Officer, Chairman of the Board of Directors, & Co-Founder
Sundar has been with the Company since its inception. Dr. Rajendran’s medical practice in anesthesia spans two decades with emphasis on continuous nerve block procedures for surgery. He trains clinicians in ultrasound guided regional anesthesia, provides medical opinion leadership for the Company and is a faculty member at the University of Colorado Medical Center. Dr. Rajendran received his MD from the University of Nebraska and completed his residency at St. Luke’s University of Missouri at Kansas City program in Kansas City. He also completed a fellowship in Regional Anesthesia at Virginia Mason Medical Center.
Co-Chief Medical Officer, Director, & Co-Founder
Dan founded and has been with the Company since its inception. Dr. Kopacz has been an advocate and pioneer in regional anesthesia for more than 25 years. He has published more than 80 scientific articles and authored book chapters on the topic of regional anesthesia. Dr. Kopacz was on the Editorial Board of Regional Anesthesia and Pain Management (ASRA) and was influential for improving medical residency requirements in anesthesiology to include mandatory regional anesthesia training. Dr. Kopacz has been on the Editorial Boards of the American Society of Anesthesiology’s (ASA) Self-Education and Evaluation Program (SEE) and Anesthesiology Continuing Education (ACE) programs. He is currently co-editor of the Continuing Medical Education program for the Journal Anesthesiology. Dr. Kopacz completed a Regional Anesthesia Fellowship at Virginia Mason Medical Center in Seattle.
President and CEO
Steve is a seasoned business builder and business development professional with leadership in predictive analytics, drug delivery, medical devices, business development, entrepreneurship, and strategic planning in private and public companies. Having done business around the world, he is an internationalist and completing more than $1.2 billion in international project fundings. Earlier in his career, he served as the CEO of Consonus, MacroMed, and CFO of Evans and Sutherland Computer Corporation and held senior development, financial and management positions at Guardian Industries, Air Products and Chemicals and Ford Motor Company. Mr. Eror holds a BA in Economics and French and an MBA from the University of Utah where he was an adjunct professor of Finance in the David Eccles Graduate School of Business.
Chief Financial Officer
Stephen Spencer, CPA, is the CFO of Solo-Dex since October, 2021. He was trained as a senior auditor by PwC in Los Angeles and Salt Lake City. Stephen is a senior financial manager with a strong background in financial analysis, internal controls, financial reporting, consolidations, technical accounting and SEC reporting. He has a track record of professionalism with a passion for streamlining accounting processes and making improvements in both public and private organizations. His CFO engagements included SignPath Pharma Inc, a clinical stage company with a unique cardiac drug development platform. Certus Critical Care, Inc., a development stage company increasing survival and quality of life in the aftermath of stroke, cardiac arrest and hemorrhagic shock, Titin KM Biomedical Corp., an innovative medical rehabilitation device company and VitaNav, Inc. manufacturer of Kenetik, an energy drink utilizing the power of ketones.
Vicki has been with Solo-Dex since March 2021 She has been employed by Southern California Edison and the Montana State Supreme Court for 31 years in legal administration departments. She is a customer service professional with strong skills resolving operational challenges and regulatory matters.
VP Regulatory Affairs
Albert Rego, Ph.D., MBA is a scientific consultant to the regulated industries, with over thirty years of experience in the pharmaceutical and medical device industries. Areas of specialization are in the national and international regulatory aspects of the scientific testing requirements for chemical, biological, and sterilization technologies. He has experience in performing, directing, and designing, and evaluating clinical and non-clinical studies for pharmaceuticals and medical devices. Selective expertise includes chemical stability testing, medical device evaluations, statistical design and interpretation, regulatory submissions, chemical hygiene plans, analytical chemistry methodologies, and sterilization validation.
Albert Rego, Ph.D., MBA is the Official Correspondent and author of numerous 510(k) applications with successful Substantial Equivalence (SE) Clearances; including devices ranging from software driven active devices to cardiovascular devices and combination products with antimicrobial properties. Post Clearance support for sponsors includes Quality System audits, audit preparation, and participation in competent authority audits both domestically and internationally (Europe, South East Asia, Australia)
Albert Rego, Ph.D., MBA has been involved as the Official Correspondent and Author of full PMA applications and PMA supplements for Class III critical devices, including authoring virtually all sections of PMA applications.
AdvisorsRoy Mittman, MD – Orthopedic Surgery
Peter G. Thurlow, JD, MBA – Intellectual Property
Louis Breton, MBA – Business Strategy
Theodore Search, Pharm D. – Marketing
Brian Harrington, MD – Anesthesia
Derek Sakata, MD - Anesthesia
Cynthia Tsai - Business Strategy